Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

The TrichoConcept™ line is effective for personalized hair loss treatments.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.

Oral cyclosporine works better than betamethasone minipulse therapy for treating Alopecia Areata.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

A 6-year-old girl was diagnosed with a rare hair disorder and started treatment with topical minoxidil.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.